🇨🇦 Discontinuation of imipenem-cilastatin or meropenem in Canada

Discontinuation of imipenem-cilastatin or meropenem (Discontinuation of imipenem-cilastatin or meropenem) regulatory status in Canada.

Marketing authorisation

Discontinuation of imipenem-cilastatin or meropenem in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Discontinuation of imipenem-cilastatin or meropenem approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Discontinuation of imipenem-cilastatin or meropenem in Canada?

Amsterdam UMC, location VUmc is the originator. The local marketing authorisation holder may differ — check the official source linked above.